Fosinopril Sodium Tablet
NDC 62135-043
Product Information
Fosinopril Sodium is a ANDA-approved product labeled by Chartwell Rx, Llc. Fosinopril is used to treat high blood pressure (hypertension). It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 62135-043 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
CE;97
CE;98
CE;99
Code Structure Chart
Product Details
What is NDC 62135-043?
What are the uses of this product?
What are Active Ingredients of this product?
- FOSINOPRIL SODIUM 40 mg/1 - A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- FOSINOPRIL SODIUM (UNII: NW2RTH6T2N)
- FOSINOPRILAT (UNII: S312EY6ZT8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- CROSPOVIDONE (UNII: 2S7830E561)
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- ZINC STEARATE (UNII: H92E6QA4FV)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 857169 - fosinopril sodium 10 MG Oral Tablet
- RxCUI: 857169 - FNP Sodium 10 MG Oral Tablet
- RxCUI: 857183 - fosinopril sodium 20 MG Oral Tablet
- RxCUI: 857183 - FNP Sodium 20 MG Oral Tablet
- RxCUI: 857187 - fosinopril sodium 40 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.